A virtual firm built as a $100 million experiment in public market investing.

S² Capital sign on a stone facade

S² Capital is a virtual investment firm investing $100 million of simulated capital in real public markets.

We research companies, build positions, track them against live market prices, and document every investment decision — from first thesis to final outcome. We revisit those decisions over time, measure their performance, and examine what we got right, what we got wrong, and why. All of our research and “trades” are published here, so we can exchange ideas and learn together.

Live · Current simulated portfolio value (Close 20 NOV 2026)

$$111188,001144,116655

Since inception +18.01%

Performance

Fund

S² Capital

Broad market
Sector

Pick one or more benchmarks to compare · indexed to 100 at inception · total return in US$

90100110120130140150 131.8118.0105.5
SEP 25NOV 25JAN 26MAR 26MAY 26JUL 26SEP 26NOV 26

Since inception, against the market

Start (24 SEP 2025) Latest Return S² excess
S² Capital $100,000,000 $118,014,165 +18.01% —
S&P 500via SPY $659.67Intraday low (demo) $689.81 +5.55%price +4.57% +12.47 pp
Health Care Select Sectorvia XLV $136.16Intraday low (demo) $177.24 +31.76%price +30.17% −13.75 pp

Total return on both sides: dividends are counted net of 15% US withholding tax and held as cash, not reinvested. The fund's cash also earns interest at the 13-week T-bill rate. Benchmarks are tracked through the ETF shown. Benchmarks outside the US are converted to US dollars at each day's exchange rate, and their dividends are counted net of the fund's default 15% withholding rate.

Dividends, net
$728,236.64
Withholding tax
$128,512.36
Cash interest
$3,590,458.84
Commissions
$0.00
Slippage
$9,994.99
Cash
$84,318,730.45

Research

  1. 24 SEP 2025 Research Merck & Co.: pricing in the Keytruda cliff too early Merck & Co. (MRK) Invested

Holdings

TickerCompanySharesCost basis Market valueWeightUnrealized return
MRK Merck & Co. 251,985 $19,999,965$79.37/sh $33,695,434$133.72/sh 28.55% +68.48%+$13,695,469
Cash USD, earning the 13-week T-bill rate — — $84,318,730 71.45% —

Valued at the 20 NOV 2026 close. Cost basis includes commissions and slippage; unrealized return excludes dividends received ($728,237 net so far).

Trades

Trade Decision Executed Price convention Shares Fill price Gross consideration Commission Slippage Cash after Weight after
BUY MRK 24 SEP 2025 08:30 ET 24 SEP 2025 Intraday low (demo)ref $79.33 251,985 $79.3697 $19,999,965.04 $0.00 $9,994.995 bps $80,000,034.96 20.00%

Investment history

  1. 15 SEP 2026 Dividend Merck & Co. (MRK) $0.85/sh × 251,985 $182,059.16 net (15% WHT)
  2. 15 JUN 2026 Dividend Merck & Co. (MRK) $0.85/sh × 251,985 $182,059.16 net (15% WHT)
  3. 16 MAR 2026 Dividend Merck & Co. (MRK) $0.85/sh × 251,985 $182,059.16 net (15% WHT)
  4. 15 DEC 2025 Dividend Merck & Co. (MRK) $0.85/sh × 251,985 $182,059.16 net (15% WHT)
  5. 24 SEP 2025 Entry Merck & Co. (MRK) Buy 251,985 sh $79.37 / $20.0M
  6. 24 SEP 2025 IC Decision Merck & Co. (MRK) Invest —
  7. 24 SEP 2025 Founded S² Capital Fund opened $100,000,000

Currencies

CHF Swiss franc

1.1847 -4.58% 1Y

1.3103 1.1847

21 NOV 202520 NOV 2026

EUR Euro

1.0970 -4.90% 1Y

1.2018 1.0970

21 NOV 202520 NOV 2026

HKD Hong Kong dollar

0.1276 -0.71% 1Y

0.1287 0.1274

21 NOV 202521 NOV 2026

CNY Chinese yuan

0.1501 +6.68% 1Y

0.1504 0.1407

21 NOV 202521 NOV 2026

US dollars per one unit of each currency, daily close, past 12 months to 21 NOV 2026. Each chart has its own scale.

Market hours

Shanghai Shanghai Stock Exchange · 09:30–11:30, 13:00–15:00 local

Hong Kong HKEX · 09:30–12:00, 13:00–16:00 local

Zurich SIX Swiss Exchange · 09:00–17:30 local

Frankfurt Xetra · 09:00–17:30 local

New York New York Stock Exchange · 09:30–16:00 local

Regular trading sessions, Monday to Friday, shown in your local time. Exchange holidays and shortened days are not shown.

It's past midnight.

I hope you're doing alright.

Take care of yourself.